Prescribing

The NHS Cheshire and Merseyside Area Prescribing Group (APG) and its subgroups provide a framework to coordinate the integration of safe, clinically effective and cost-effective medicines across Cheshire and Merseyside. Improved outcomes and an improved experience for patients are central to the decision-making process.  

The APG is a professional group consisting of GPs, pharmacists, and other key healthcare professionals who are responsible for ensuring robust standards and governance for decision-making.

  • Policies and Reports

    APG policy, APG terms of reference, Conflicts of interest, RAG definitions, Free-of-charge schemes, Out-of-area requests, Fast-track process, and NICE TA adherence.

  • APG subgroups

    New medicines, Formulary and guidelines, Interface prescribing, Safety, and Antimicrobial guide

  • Forms and applications

    New service developments, individual funding requests, and appeals process

  • Publications

    APG approvals report

  • Wegovy™ access in Cheshire and Merseyside

    Wegovy® (Semaglutide) – a weight-management treatment – is currently only available to NHS patients via specialist Tier 3 or 4 weight management services.

  • Valproate

    New regulatory measures for oversight of prescribing to new patients and existing female patients

  • Update on ADHD medication shortage

    We are providing an important update on the ongoing Attention Deficit Hyperactivity Disorder (ADHD) medication shortages affecting the UK. 

Contact

For medicines optimisation enquiries, please email: Mop-enquiries@cheshireandmerseyside.nhs.uk